Press Release: EDAP completes FDA inspection of manufacturing site

LYON, France -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the U.S. Food and Drug Administration (FDA) concluded its routine inspection of EDAP's manufacturing site with no findings nor issuance of Form 483 observations.

EDAP TMS SA, Food & Drug Administration (FDA)

News Well, Press Release, Food & Drug Administration (FDA), Oncology, Pre-Market Approval (PMA), Prostate, Regulatory/Compliance, Ultrasound

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/V2qG5d